The Testing Evidence for Using Fenbendazole for Treating Soft Tissue Cancer

Executive Summary

• This article covers the evidence I could find for Fenbendazole as a treatment for Soft Tissue Cancer.

Article Summary

Studies demonstrate that Fenbendazole is effective against cancer, we then cover how Fenbendazole works against cancer by explaining the mechanisms of action, and then the impacts of Fenbendazole on cancer.

Introduction

This article provides an overview covering the evidence for Fenbendazole and related drugs versus Soft Tissue Cancer.

Many articles on this website cover the evidence for the benefits of Fenbendazole for cancer. But the question of which specific cancers Fenbendazole has been proven effective is a constant source of questions.

The most common Benzimidazoles are Fenbendazole, Mebendazole and Albendazole. In our analysis, we include research for all three drugs together in articles as they are very similar to one another and it improves the ability to tie together different studies. You may see the following terms/acronyms used.

• FZ or FBZ means Fenbendazole
• MBZ means Mebendazole
• AZ means Albendazole

Cancer Type #18: Soft Tissue Cancer

I could not find any studies of Fenbendazole versus different types of cancer.

However, given the performance of Fenbendazole versus other types of cancer, it is very likely that Fenbendazole is effective against Soft Tissue Cancer.

Why Fenbendazole is Currently and Will Most Likely Only Ever be Approved by the FDA as an Antiparasitic Drug for Animals

Fenbendazole is only approved by the FDA as an anti-parasitical and has been for over 50 years -- and it is not approved for humans. But the likelihood is essentially zero that any pharmaceutical company will ever go to the expense to perform a clinical trial on Fenbendazole to expand its usage outside of antiparasitics and for humans. Because there are no profits to be made from such an endeavor -- and that is the only way drugs are approved, a pharmaceutical company must invest the money into performing two clinical trials. The reason for this is that Fenbendazole has already fallen off of its patent. 

Pharmaceutical companies are far more likely to fund studies to undermine Fenbendazole, as Bill Gates' foundation did with Hydroxychloroquine.

The US Government Health Authorities Are Aligned With Promoting Only Patent Drugs

Studies have continued on Fenbendazole, but the NIH or any other pharmaceutical company will not fund them. However, at the direction of pharmaceutical companies, the FDA actively discourages using Fenbendazole.

Case Study #1: The FDA’s Statement and Laetrile

This is concisely explained in the quote from William W Vodra, Former Associate Chief Council for the FDA.

No one is going to pay $70,000 for a new cancer drug if they can buy Laetrile for 75 cents.

Laetrile was a drug that was shut down in the 1970s by the medical establishment (specifically Sloan Kettering) that showed promise against cancer. Laetrile is the topic of the documentary The Lie of America's War on Cancer. However, this quote from Vodra is from the 1970s.

Today, the average new chemotherapy drug is over $200,000, and immunotherapy drugs are over $300,000.

What is curious about this admission by Vodra is that it is not made by a pharmaceutical company -- which would be entirely expected. Instead, it is made by a top official at the FDA.

When you can't distinguish quotes from pharmaceutical companies and a drug regulator like the FDA, one has to question how independent that drug regulator is. 

It's apparent that neither the FDA nor NIH cares about the evidence supporting Fenbendazole. And this is not just an issue limited to Fenbendazole. While patent drugs constantly have their off-label usage expanded without any studies submitted to the FDA.

MDs are given negative reinforcement for using Fenbendazole for anything but as an antiparasitic. Fenbendazole usage as an animal antiparasitic is for a much shorter duration than using Fenbendazole against cancer. The dosage is also much lower as an antiparasitic. However, by contrast, antidepressants or statins constantly have their usage expanded without any new clinical trials being submitted because they are preferred drugs. 

The reality is that generic drugs are considered drugs the pharmaceutical industry wants to de-emphasize -- hopefully (that is the hope of the pharmaceutical companies) to be replaced by an on-patent drug at some point in the future. In the case of drugs Paxlovid and Molnupiravir, both were promoted by the medical establishment to replace the generic Ivermectin versus covid, even though both were useless against covid and far more expensive than either Ivermectin or Fenbendazole and were far less safe drugs. The promotion of Paxlovid and Molnupiravir and the impression of Ivermectin by the medical establishment (including the FDA) and the establishment media should tell you all you need to know about how they work. 

More About The C19Early Clinical Trial Comparison Website

The C19early.com website tracks clinical trials. It is the best source of information on the studies of the effectiveness based upon clinical trials of different treatments for covid. However, it is more than this - as it is a model for how clinical trials should be communicated to the public so the extraordinarily corrupt medical establishment does not control the information. And it is the website that the medical establishment would like banned from the Internet.

One of the things the C19Early website showed was that early treatment significantly impacted the outcomes against covid.

The Benefit of Early Treatment

Notice that the earlier the treatment is used, the better the outcomes. Naturally, early treatment is measured in days with a respiratory disease like COVID-19, while in months with a disease like cancer. So the timings are different, but the principle is the same. 

Even though this website does not track cancer clinical trials (unfortunately, no website does), the site holds essential observations. For one, a person's response to covid is like their response to cancer, greatly dependent upon the strength and health of their immune system.

Things like Zinc, Ivermectin, and Fenbendazole all empower the immune system and are, therefore, effective in the treatment and prevention of both COVID and cancer. 

Offering Cancer Prevention as Well as Treatment

What is better than treatment is prevention. For anyone who is concerned with cancer prevention, both a very healthy lifestyle and diet, as well as things like Ivermectin and or Fenbendazole, are things that can be taken both as a treatment and as a preventative. We cover all these topics and the supporting specifics on our subscription website. 

Adding up the Studies of Fenbendazole Versus Cancer

There are many studies of Fenbendazole, Mebendazole, Albendazole, and other Benzimidazole derivatives versus cancer.

Due to the success of these studies and the information published in the study publications, the specific mechanisms by which these Benzimidazole-based Anthelmintics work against cancer are at this point well understood. There has not been a study published for every cancer type using one of the Benzimidazole derivatives. There are a very large number of different cancer types and limited funding for this type of research.

How Many Major Cancer Types Are There Studies For?

When I completed my analysis, I found 18 different types of cancer types which demonstrated effectiveness versus cancer. In many cases, these different cancer types had multiple cancer studies testing the different Benzimidazole derivatives.

Cancer centers do not apply the large body of published studies on the effectiveness of Benzimidazole derivatives to include as part of their treatment offerings. This is true even though Fenbendazole has been demonstrated to improve chemotherapy outcomes.

To understand the mechanisms by which Benzimidazole derivatives work against cancer, see the following few examples. To see all of the known mechanisms that I have compiled from all of the studies see the article on the mechanisms listed below.

The Multiple Mechanisms by Which Fenbendazole Works Against Cancer

There are many ways in which Fenbendazole works against cancer including.

• Reducing metastasis
• Increase autophagy
• Increase cancer cell death or apoptosis
• and much more

This topic is covered in the article By How Many Different Mechanisms Does Fenbendazole Fight Cancer?